TipRanks
Go Ultimate55% OFF

TG Therapeutics (0VGI) Share Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

0VGI Analyst Ratings

Moderate Buy
5Ratings
4Buy0Hold1Sell
Based on 5 analysts giving stock ratings to TG Therapeutics in the past 3 months

0VGI Stock 12 Month Forecast

$65.00▲(14.64% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for TG Therapeutics in the last 3 months. The average price target is $65.00 with a high forecast of $86.00 and a low forecast of $21.00. The average price target represents a 14.64% change from the last price of $56.70.
Highest Price Target$86.00Average Price Target$65.00Lowest Price Target$21.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for GB:0VGI
Price TargetFollowArticle
J.P. Morgan―buy―Reiterated10/25/26
H.C. Wainwright$78buy37.57%UpsideReiterated09/21/26
B. Riley Securities$86buy51.68%UpsideReiterated09/02/26
Bank of America Securities$20→$21sell-62.96%DownsideReiterated08/05/26
TD Cowen$75buy32.28%UpsideReiterated08/03/26
Jefferies$83buy46.38%UpsideReiterated07/14/26
Goldman Sachs$41hold-27.69%DownsideReiterated06/03/26
Citi$46→$49buy-13.58%DownsideReiterated11/03/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
MDWDMediwound
IMUXImmunic
RZLTRezolute
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering TG Therapeutics

3 Months
Success Rate10/14 ratings generated profit
71%
Average Return
+10.17%

Copying Tara Bancroft's trades and holding each position for 3 Months would result in 71.43% of your transactions generating a profit, with an average return of +10.17% per trade.

1 Year
Success Rate14/17 ratings generated profit
82%
Average Return
+72.65%

Copying Eric Joseph's trades and holding each position for 1 Year would result in 82.35% of your transactions generating a profit, with an average return of +72.65% per trade.

2 Years
Success Rate14/14 ratings generated profit
100%
Average Return
+58.44%

Copying Tara Bancroft's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +58.44% per trade.

0VGI Analyst Recommendation Trends

05101520Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for 0VGI
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy67753
Buy37674
Hold43100
Sell00000
Strong Sell22321
total151917148

In the current month, 0VGI has received 7 Buy Ratings, 0 Hold Ratings, and 1 Sell Ratings. 0VGI average Analyst price target in the past 3 months is 65.00.

0VGI Financial Forecast

$-1$0$1$2$3Q4 2025Q2 2026Q3 2026
High$0.63
Consensus$0.37
Low$0.19

0VGI Earnings Forecast

Next quarter’s earnings estimate for 0VGI is $0.37 with a range of $0.19 to $0.63. The previous quarter’s EPS was $0.05. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$161.7M$185M$208.3M$231.7M$255MQ4 2025Q2 2026Q3 2026
High$255M
Consensus$245M
Low$232M

0VGI Sales Forecast

Next quarter’s sales forecast for 0VGI is $245.47M with a range of $232.00M to $254.99M. The previous quarter’s sales results were $240.34M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

0VGI Stock Forecast FAQ

What is GB:0VGI’s average 12-month price target, according to analysts?
Based on analyst ratings, TG Therapeutics’s 12-month average price target is $65.00.
What is GB:0VGI’s upside potential, based on the analysts’ average price target?
TG Therapeutics has 14.64% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TG Therapeutics a Buy, Sell or Hold?
TG Therapeutics has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 0 hold ratings and 1 sell ratings.
What is TG Therapeutics’s share price target?
The average share price target for TG Therapeutics is $65.00. This is based on 5 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is $86.00, and the lowest forecast is $21.00. The average share price target represents a 14.64% increase from the current price of $56.7.
What do analysts say about TG Therapeutics?
TG Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 5 Wall Street analysts.
How can I buy shares of TG Therapeutics?
To buy shares of GB:0VGI, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.